- Home
- PSIX vs GLPG Comparison
PSIX vs GLPG Comparison
Compare PSIX & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSIX
- GLPG
- Stock Information
- Founded
- PSIX 1985
- GLPG 1999
- Country
- PSIX United States
- GLPG Belgium
- Employees
- PSIX N/A
- GLPG N/A
- Industry
- PSIX Industrial Machinery/Components
- GLPG Biotechnology: Pharmaceutical Preparations
- Sector
- PSIX Industrials
- GLPG Health Care
- Exchange
- PSIX Nasdaq
- GLPG Nasdaq
- Market Cap
- PSIX 2.0B
- GLPG 2.1B
- IPO Year
- PSIX N/A
- GLPG 2005
- Fundamental
- Price
- PSIX $52.86
- GLPG $30.78
- Analyst Decision
- PSIX
- GLPG Hold
- Analyst Count
- PSIX 0
- GLPG 4
- Target Price
- PSIX N/A
- GLPG $31.33
- AVG Volume (30 Days)
- PSIX 932.0K
- GLPG 173.1K
- Earning Date
- PSIX 11-06-2025
- GLPG 11-05-2025
- Dividend Yield
- PSIX N/A
- GLPG N/A
- EPS Growth
- PSIX 122.27
- GLPG N/A
- EPS
- PSIX 5.26
- GLPG N/A
- Revenue
- PSIX $675,481,000.00
- GLPG $336,643,201.00
- Revenue This Year
- PSIX $29.80
- GLPG $1.77
- Revenue Next Year
- PSIX $11.99
- GLPG $0.44
- P/E Ratio
- PSIX $9.92
- GLPG N/A
- Revenue Growth
- PSIX 54.78
- GLPG 10.31
- 52 Week Low
- PSIX $15.30
- GLPG $22.36
- 52 Week High
- PSIX $121.78
- GLPG $37.78
- Technical
- Relative Strength Index (RSI)
- PSIX 29.65
- GLPG 43.81
- Support Level
- PSIX $51.53
- GLPG $30.13
- Resistance Level
- PSIX $57.54
- GLPG $31.06
- Average True Range (ATR)
- PSIX 6.89
- GLPG 0.75
- MACD
- PSIX -1.63
- GLPG -0.04
- Stochastic Oscillator
- PSIX 18.36
- GLPG 29.62
About PSIX Power Solutions International Inc. Common Stock
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.